{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:44:01Z","timestamp":1791067441290,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.spinee.2012.09.052","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T22:45:45Z","timestamp":1350945945000},"page":"894-899","source":"Crossref","is-referenced-by-count":94,"title":["Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience\u00a0database"],"prefix":"10.1016","volume":"12","author":[{"given":"Emily Jane","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2012.09.052_bib1","unstructured":"Premarket approval. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPMA\/pma.cfm. (PMA P000058, original application and supplement S002). Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib2","unstructured":"INFUSE Bone Graft package insert. Available at: www.infusebonegraft.com\/spine_package_insert.pdf. Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"9 Suppl","key":"10.1016\/j.spinee.2012.09.052_bib4","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/BRS.0b013e3181d81ef2","article-title":"Complications related to osteobiologics use in spine surgery: a systematic review","volume":"35","author":"Mroz","year":"2010","journal-title":"Spine"},{"issue":"5 Suppl 2","key":"10.1016\/j.spinee.2012.09.052_bib5","doi-asserted-by":"crossref","first-page":"ONS423","DOI":"10.1227\/01.neu.0000326030.24220.d8","article-title":"A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery","volume":"62","author":"Benglis","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2012.09.052_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J Spinal Disord"},{"key":"10.1016\/j.spinee.2012.09.052_bib7","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1097\/00007632-200212010-00005","article-title":"Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies","volume":"27","author":"Boden","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib8","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","article-title":"Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine","volume":"31","author":"Smucker","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","article-title":"Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)","volume":"19","author":"McClellan","year":"2006","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2012.09.052_bib10","unstructured":"Manufacturer and User Facility Device Experience Database. Available at: http:\/\/www.fda.gov\/medicaldevices\/deviceregulationandguidance\/postmarketrequirements\/reportingadverseevents\/ucm127891.htm. Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib11","unstructured":"FDA Public Health Notification: life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. Available at: http:\/\/www.fda.gov\/medicaldevices\/safety\/alertsandnotices\/publichealthnotifications\/ucm062000.htm. Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","article-title":"Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion","volume":"31","author":"Shields","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib13","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1097\/01.brs.0000216442.12092.01","article-title":"Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2","volume":"31","author":"Pradhan","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2012.09.052_bib15","doi-asserted-by":"crossref","first-page":"W128","DOI":"10.2214\/AJR.10.5484","article-title":"Radiographic and CT evaluation of recombinant human bone morphogenetic protein-2-assisted spinal interbody fusion","volume":"197","author":"Sethi","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.spinee.2012.09.052_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3171\/2009.4.SPINE0876","article-title":"Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion","volume":"12","author":"Chen","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.spinee.2007.06.014","article-title":"Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF\/TLIF use of bone morphogenetic protein-2 (BMP-2)","volume":"8","author":"Wong","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2012.09.052_bib18","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/BRS.0b013e31815b7596","article-title":"Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis","volume":"32","author":"Joseph","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2106\/JBJS.H.00200","article-title":"Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis","volume":"91","author":"Dimar","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2012.09.052_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.BRS.0000065486.22141.CA","article-title":"A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate","volume":"28","author":"Baskin","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","article-title":"Confounding by indication: an example of variation in the use of epidemiologic terminology","volume":"149","author":"Salas","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.spinee.2012.09.052_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2012.09.052_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.spinee.2012.09.040","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a ten-year cohort controlled study","author":"Comer","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2012.09.052_bib24","unstructured":"Center for Devices and Radiological Health Medical Devices Advisory Committee, Orthopedic and Rehabilitation Devices Panel. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/MedicalDevices\/MedicalDevicesAdvisoryCommittee\/OrthopaedicandRehabilitationDevicesPanel\/UCM225538.pdf. Accessed September 22,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/BRS.0b013e3181ecf6e4","article-title":"Off-label use of bone morphogenetic proteins in the United States using administrative data","volume":"35","author":"Ong","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2012.09.052_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2009.956","article-title":"Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures","volume":"302","author":"Cahill","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.spinee.2012.09.052_bib27","unstructured":"Premarket approval. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPMA\/pma.cfm. (PMA P000058, supplements S007, S020, S027, and S032). Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib28","unstructured":"Spine safety alert supplement. Available at: http:\/\/www.spine.org\/Documents\/rhBMP_cervical_7-08_rev _2_.pdf. Accessed September 21,\u00a02012."},{"key":"10.1016\/j.spinee.2012.09.052_bib29","unstructured":"BMP for cervical fusion? Available at: http:\/\/www.spine.org\/Pages\/Publications\/SpineLine\/CurveSurvey\/Archives\/cc_sle08julaug.aspx. Accessed September 21,\u00a02012."}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943012012429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943012012429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T01:25:16Z","timestamp":1542677116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943012012429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1529943012012429"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2012.09.052","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}